Τushar Garimella
- Nephrology top 2%
- Hepatology top 5%
- Hepatitis C virus research 18
- Pharmacology top 5%
- Pharmacogenetics and Drug Metabolism 5
-
- HIV/AIDS drug development and treatment 14
-
- HER2/EGFR in Cancer Research 11
- Drug Transport and Resistance Mechanisms 7
-
- Liver Disease Diagnosis and Treatment 10
-
- Monoclonal and Polyclonal Antibodies Research 9
-
- Pharmacological Effects and Toxicity Studies 5
- Co-authors
- Yili PritchettPaul AudhyaDennis L. AndressHans‐Henrik ParvingMichael AmdahlDaniel W. CoyneDick de ZeeuwRajiv Agarwal
- Partner nations
- United StatesJapanGermany
In The Last Decade
Τushar Garimella
41 papers receiving 1.3k citations
Hit Papers
Peers
Comparison fields: 5 of 88
- Nephrology 384
- Hepatology 185
- Pathology and Forensic Medicine 321
- Pharmacology 101
- Endocrinology, Diabetes and Metabolism 163
Countries citing papers authored by Τushar Garimella
This map shows the geographic impact of Τushar Garimella's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Τushar Garimella with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Τushar Garimella more than expected).
Fields of papers citing papers by Τushar Garimella
This network shows the impact of papers produced by Τushar Garimella. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Τushar Garimella. The network helps show where Τushar Garimella may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Τushar Garimella, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 2 | |
| 2 | 2025 | 1 | |
| 3 | 2024 | 0 | |
| 4 | 2023 | 1 | |
| 5 | 2023 | 9 | |
| 6 | 2018 | 40 | |
| 7 | 2018 | 4 | |
| 8 | 2018 | 50 | |
| 9 | 2017 | 20 | |
| 10 | 2017 | 11 | |
| 11 | 2016 | 21 | |
| 12 | 2014 | 5 | |
| 13 | 2012 | 46 | |
| 14 | 2011 | 0 | |
| 15 | 2011 | 194 | |
| 16 | 2010 | 32 | |
| 17 | Selective vitamin D receptor activation with paricalcitol for reduction of albuminuria in patients with type 2 diabetes (VITAL study): a randomised controlled trialbreakdown → | 2010 | 520 |
| 18 | 2004 | 19 | |
| 19 | 2004 | 14 | |
| 20 | 2001 | 59 |
About Τushar Garimella
Τushar Garimella is a scholar working on Hepatology, Pharmacology and Infectious Diseases, having authored 44 papers that have together received 1.4k indexed citations. Recurring topics across this work include Hepatitis C virus research (18 papers), HIV/AIDS drug development and treatment (14 papers), HER2/EGFR in Cancer Research (11 papers), Liver Disease Diagnosis and Treatment (10 papers), Monoclonal and Polyclonal Antibodies Research (9 papers), Drug Transport and Resistance Mechanisms (7 papers), Pharmacogenetics and Drug Metabolism (5 papers) and Pharmacological Effects and Toxicity Studies (5 papers). The work is most often cited by research in Nephrology (384 citations), Hepatology (185 citations) and Pathology and Forensic Medicine (321 citations). Τushar Garimella has collaborated with scholars based in United States, Japan and Germany. Frequent co-authors include Yili Pritchett, Paul Audhya, Dennis L. Andress, Hans‐Henrik Parving, Michael Amdahl, Daniel W. Coyne, Dick de Zeeuw, Rajiv Agarwal, Giuseppe Remuzzi and Eberhard Ritz. Their work appears in journals such as The Lancet, Journal of Clinical Oncology and Cancer Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.